Today: 1 July 2026
PepsiCo stock slips into Presidents Day break as buyback plan meets rate jitters
15 February 2026
1 min read

PepsiCo stock slips into Presidents Day break as buyback plan meets rate jitters

New York, Feb 15, 2026, 15:46 EST — Market closed

PepsiCo Inc (PEP) ended Friday off 0.8%, settling at $165.94. Shares traded from $165.00 up to $167.88 during the day, with roughly 9.3 million shares changing hands.

The stock heads into a holiday-cut week, as the NYSE closes Monday for Washington’s Birthday, reopening Tuesday. With fewer trading days, volume typically drops—making any macro headline pack more punch.

PepsiCo zeroed in on its February 3 update, holding firm to its 2026 outlook. The company bumped its yearly dividend up to $5.92 a share from $5.69, effective with the anticipated June payment, and put a new repurchase program on the table—potentially reaching $10 billion through February 28, 2030. The 2026 forecast hasn’t wavered: organic revenue up 2% to 4% (stripping out FX and deals) and core EPS growth at 4% to 6% in constant currency. For this year, PepsiCo figures it will hand back about $8.9 billion to shareholders. CEO Ramon Laguarta said the strategy aims to “offer sharper value,” noting customers are watching prices more closely. PepsiCo Investors

U.S. inflation cooled in January, pushing bond yields lower, but the market couldn’t shake off its slump on Friday. The CPI rose 2.4% year-over-year, missing the 2.5% consensus estimate. The Dow ticked up 0.10%, while the S&P 500 barely registered a 0.05% advance, Reuters reported.

Phil Orlando, chief market strategist at Federated Hermes, had a quick take after the numbers landed: “The inflation report is better than expected.” For the Fed, he said, that’s “good news”—especially with investors still sorting out both the timing and pace of potential rate cuts. Reuters

PepsiCo’s next moves have investors guessing: how far can it push “value” deals before margins start to hurt? On Feb. 3, the company said it would cut U.S. prices on major snacks—Lay’s, Doritos—by as much as 15%, reacting to pushback on earlier price increases. Executives also pointed to rising demand for portion-control snacks, linking that trend to more Americans taking GLP-1 weight-loss drugs. Reuters

On the call, Laguarta flagged affordability as “the biggest friction” for some shoppers, with low- and middle-income buyers feeling the pinch. CFO Steve Schmitt added, “we’re playing offense here,” and said the North America investment plan is “manageable”—already baked into guidance, he noted.

Results were mixed among peers. Coca-Cola dipped 0.4%, while the Consumer Staples Select Sector SPDR Fund (XLP) edged up roughly 0.3% by the close.

PepsiCo’s board signed off on a $1.4225 quarterly dividend per share, payable March 31 to investors holding shares as of March 6.

Still, betting on affordability could backfire. If lower shelf prices don’t actually move the needle on volume, PepsiCo could end up giving up margin with little payoff—especially if competitors jump in with similar offers and retailers demand more incentives just to keep the products stocked.

Eyes are on Wednesday, as the Federal Reserve is set to publish minutes from its Jan. 27-28 meeting. The details go live at 2:00 p.m. ET Feb. 18.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • ASX 200 trails global indexes in 2026 as key healthcare names dive
    July 1, 2026, 3:42 AM EDT. The ASX 200 barely managed a gain of less than 2.8% for the 2026 financial year, outpaced by major overseas markets. The rise was negative after inflation. US stocks soared, with the S&P 500 up 20.8%, NASDAQ up 28.7%, and Europe's STOXX 600 climbing 19%. Losses for CSL-off 52%-and Cochlear, down almost 60%, weighed on the Australian market. Bank results were mixed; ANZ gained 16% but Commonwealth Bank and NAB lagged. 4D Medical stood out with strong returns while the rest of the market barely moved.
Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next
Previous Story

Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop